Cryoport, Inc. ("Cryoport"), a global leader in supply chain solutions for the life sciences industry, and SK pharmteco, a global contract development and manufacturing organization, today announced a ...

Discover Editas Medicine's groundbreaking patent for enzymatically active Cas9 fusion molecules, enhancing gene editing precision with innovative nucleic acid applications.

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic disorders and cancer due to ...

You should also note that the Gene-Seed and the Guardian Relic share the same inventory slot. This means that the player ...